CRISPR Therapeutics AG

NasdaqGM:CRSP Stock Report

Market Cap: US$5.5b

CRISPR Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:CRSP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Aug 25BuyUS$1,140,600Douglas TrecoIndividual20,000US$57.03
16 Jul 25BuyUS$51,499,918SR One Capital Management, LPCompany989,812US$52.03
26 Feb 25BuyUS$313,948John GreeneIndividual7,000US$44.85
19 Feb 25SellUS$280,790Samarth KulkarniIndividual5,318US$52.80

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CRSP?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders498,2110.523%
General Public23,492,42124.7%
Institutions71,309,60174.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 62.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.3%
ARK Investment Management LLC
9,786,973US$569.4m-3.89%3.38%
7.4%
BlackRock, Inc.
7,050,145US$410.2m16.2%0.01%
6.15%
Capital Research and Management Company
5,857,114US$340.8m1.15%0.01%
5.23%
Orbis Investment Management Limited
4,982,085US$289.9m80.2%0.72%
4.2%
State Street Global Advisors, Inc.
4,007,233US$233.1m22.5%0.01%
3.52%
T. Rowe Price Group, Inc.
3,359,119US$195.4m-10.4%0.02%
2.48%
The Vanguard Group, Inc.
2,364,645US$137.6m2.9%no data
2.45%
UBS Asset Management AG
2,339,056US$136.1m-38.6%0.01%
2.27%
Amova Asset Management Co., Ltd.
2,163,675US$125.9m-10.4%0.04%
2.25%
Geode Capital Management, LLC
2,141,170US$124.6m3.34%0.01%
2.14%
SR One Capital Management, LP
2,038,763US$118.6m94.4%15.22%
1.97%
FMR LLC
1,880,734US$109.4m-2.33%0.01%
1.46%
EcoR1 Capital, LLC
1,389,276US$80.8m0%3.3%
1.43%
Morgan Stanley
1,366,209US$79.5m182%0.01%
1.11%
New Enterprise Associates, Inc.
1,058,570US$61.6m-33.3%3.06%
1.1%
Two Sigma Investments, LP
1,044,689US$60.8m-32.4%0.1%
1.03%
Charles Schwab Investment Management, Inc.
985,770US$57.4m5.63%0.01%
0.95%
Loomis Sayles & Company, L.P.
909,714US$52.9m6.16%0.06%
0.92%
Dimensional Fund Advisors LP
877,029US$51.0m-4.43%0.01%
0.89%
Susquehanna International Group, LLP
851,818US$49.6m6.35%0.07%
0.82%
Northern Trust Global Investments
779,930US$45.4m2.47%0.01%
0.74%
Merrill Lynch, Pierce, Fenner & Smith Incorporated
701,389US$40.8m1.71%0.01%
0.6%
Two Sigma Advisers, LP
572,972US$33.3m-57.4%0.07%
0.54%
JP Morgan Asset Management
513,504US$29.9m104%no data
0.43%
Norges Bank Investment Management
406,487US$23.6m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/05 04:18
End of Day Share Price 2025/12/05 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CRISPR Therapeutics AG is covered by 47 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Huidong WangBarclays
Konstantinos BiliourisBMO Capital Markets Equity Research